Noninferiority of closely monitored mechanical valves to bioprostheses overshadowed by early mortality benefit in younger patients

Annals of Thoracic Surgery

Volumn 93, Issue 3, 2012, Pages 748-753

  Badhwar, Vinay ^a   Ofenloch, John C ^a   Rovin, Joshua D ^a   Van Gelder, Hugh M ^a   Jacobs, Jeffrey P ^a  

^a UNIVERSITY OF PITTSBURGH MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CREATININE;

ADULT; AGED; AORTA VALVE PROSTHESIS; ARTICLE; BIOPROSTHESIS; CREATININE BLOOD LEVEL; FEMALE; FOLLOW UP; HAZARD RATIO; HEART ATRIUM FIBRILLATION; HEART EJECTION FRACTION; HUMAN; MAJOR CLINICAL STUDY; MALE; MORTALITY; PATIENT MONITORING; POINT OF CARE TESTING; POSTOPERATIVE HEMORRHAGE; PRIORITY JOURNAL; THROMBOEMBOLISM; TRANSIENT ISCHEMIC ATTACK;

ADULT; AGE FACTORS; AGED; AORTIC VALVE; BIOPROSTHESIS; FEMALE; HEART VALVE PROSTHESIS; HUMANS; MALE; MIDDLE AGED; MITRAL VALVE; MONITORING, PHYSIOLOGIC; PROSPECTIVE STUDIES; YOUNG ADULT;

EID: 84857576483     PISSN: 00034975     EISSN: 15526259     Source Type: Journal    
DOI: 10.1016/j.athoracsur.2011.12.032     Document Type: Article

References (33)

1. S.D. Barnett, N. Ad Surgery for aortic and mitral valve disease in the United States: A trend of change in surgical practice between 1998 and 2005 J Thorac Cardiovasc Surg 137 2009 1422 1429
2. H. Koertke, A. Zittermann, O. Wagner, R. Koerfer Self-management of oral anticoagulation therapy improves long-term survival in patients with mechanical heart valve replacement Ann Thorac Surg 83 2007 24 29
3. H. Koertke, A. Zittermann, O. Wagner et al. Efficacy and safety of very low-dose self-management of oral anticoagulation in patients with mechanical heart valve replacement Ann Thorac Surg 90 2010 1487 1494
4. J.L. Thompson, T.M. Sundt, M.E. Sarano, P.J. Santrach, H.V. Schaff In-patient international normalized ratio self-testing instruction after mechanical heart valve implantation Ann Thorac Surg 85 2008 2046 2050
5. R.W. Emery, C.C. Krogh, K.V. Arom et al. The St. Jude Medical cardiac valve prosthesis: a 25-year experience with a single valve replacement Ann Thorac Surg 79 2005 776 782
6. J.M. Toole, M.R. Stroud, J.M. Kratz et al. Twenty-five year experience with the St. Jude Medical mechanical valve prosthesis Ann Thorac Surg 89 2010 1402 1409
7. M.L. Brown, H.V. Schaff, B.D. Lahr et al. Aortic valve replacement in patients aged 50 to 70 years: improved outcome with mechanical versus biologic prostheses J Thorac Cardiovasc Surg 135 2008 878 884
8. P. Stassano, L. DiTommaso, M. Monaco et al. Aortic valve replacement: a prospective randomized evaluation of mechanical versus biological valves in patients ages 55 to 70 years J Am Coll Cardiol 54 2009 1862 1868
9. S. Stoica, K. Goldsmith, N. Demiris et al. Microsimulation and clinical outcomes analysis support a lower age threshold for use of biological valves Heart 96 2010 1730 1736
10. M. Ruel, V. Chan, P. Bdard et al. Very long-term survival implications of heart valve replacement with tissue versus mechanical prostheses in adults <60 years of age Circulation 116 2007 I294 I300
11. A. Kulik, P. Bedard, B.K. Lam et al. Mechanical versus bioprosthetic valve replacement in middle-aged patients Eur J Cardiothorac Surg 30 2006 485 491
12. J. Hirsh, G. Guyatt, G.W. Albers, R. Harrington, H.J. Schunemann Executive summary: American College of Chest Physicians evidence-based clinical practice guidelines (8th edition) Chest 133 2008 71 109S
13. R.O. Bonow, B.A. Carabello, K. Chatterjee et al. 2008 Focused update incorporated into the ACC/AHA 2006 Guidelines for the management of patients With valvular heart disease: a report of the American College of Cardiology/American Heart Association task force on practice guidelines (writing committee to revise the 1998 Guidelines for the management of patients with valvular heart disease) Circulation 118 2008 e523 e661
14. C.W. Akins, D.C. Miller, M.I. Turina et al. Guidelines for reporting mortality and morbidity after cardiac valve interventions Ann Thorac Surg 85 2008 1490 1495
15. D.R. Cox Regression models and life-tables J R Stat Soc 34 1972 187 220
16. E.L. Kaplan, P. Meier Nonparametric estimation from incomplete observations J Am Stat Assoc 53 1958 547 581
17. G.L. Grunkemeier, D.M. Johnson, D.C. Naftel Sample size requirements for evaluating heart valves with constant risk events J Heart Valve Dis 3 1994 53 58
18. E.H. Blackstone Comparing apples and oranges J Thorac Cardiovasc Surg 123 2002 8 15
19. T. Kurth, A.M. Walker, R.J. Glynn et al. Results of multivariable logistic regression, propensity matching, propensity adjustment, and propensity-based weighting under conditions of nonuniform effect Am J Epidemiol 163 2006 262 270
20. G.L. Grunkemeier, J. Ruyun, A. Starr Prosthetic heart valves: objective performance criteria versus randomized clinical trial Ann Thorac Surg 82 2006 776 780
21. T.E. David, S. Armstrong, M. Maganti Hancock II bioprosthesis for aortic valve replacement: the gold standard of bioprosthetic valves durability? Ann Thorac Surg 90 2010 775 781
22. R.S. McClure, N. Narayanaswamy, E. Wiegerinck et al. Late outcomes for aortic valve replacement with the Carpentier-Edwards pericardial bioprosthesis: up to 17-year follow-up in 1,000 patients Ann Thorac Surg 89 2010 1410 1416
23. P. Biglioli, N. Spampinato, A. Cannata et al. Long-term outcomes of the Carpentier-Edwards pericardial valve prosthesis in the aortic position: effect of patient age J Heart Valve Dis 13 2004 S49 S51
24. M.K. Banbury, D.M. Cosgrove, J.A. White, E.H. Blackstone, R.W.M. Frater, J.E. Okies Age and valve size effect on the long-term durability of the Carpentier-Edwards aortic pericardial bioprosthesis Ann Thorac Surg 72 2001 753 757
25. J.S. Lawton, N. Moazami, M.K. Pasque, M.M. Moon, R.J. Damiano Jr Early stenosis of Medtronic Mosaic porcine valves in the aortic position J Thorac Cardiovasc Surg 137 2009 1556 1557
26. W. Jamieson, G. Fradet Aortic bioprosthesisavoid obstructive properties due to thrombosis as altered durability due to structural valve deterioration J Thorac Cardiovasc Surg 139 2010 1354
27. W. Flameng, M.C. Herregods, M. Vercalsteren, P. Herijgers, K. Bogaerts, B. Meuris Prosthesis-patient mismatch predicts structural valve degeneration in bioprosthetic heart valves Circulation 121 2010 2123 2129
28. J.H. Chesebro, V. Fuster Optimal antithrombotic therapy for mechanical prosthetic heart valves Circulation 94 1996 2055 2056
29. V. Chan, W.R. Jamieson, B.K. Lam et al. Influence of the on-x mechanical prosthesis on intermediate-term major thromboembolism and hemorrhage: a prospective multicenter study J Thorac Cardiovasc Surg 140 2010 1053 1058
30. A. Vahanian, H. Baumgartner, J. Bax et al. Guidelines on the management of valvular heart disease The task force on the management of valvular heart disease of the European Society of Cardiology Eur Heart J 28 2007 230 268
31. K. Hammermeister, G.K. Sethi, W.G. Henderson, F.L. Grover, C. Oprian, S.H. Rahimtoola Outcomes 15 years after valve replacement with a mechanical versus a bioprosthetic valve: final report of the Veterans Affairs randomized trial J Am Coll Cardiol 36 2000 1152 1158
32. J.G. Webb, D.A. Wood, J. Ye et al. Transcatheter valve-in-valve implantation for failed bioprosthetic heart valves Circulation 121 2010 1848 1857
33. R. Garcia-Rinaldi, C. Carro-Pagan, H.V. Schaff et al. Initial experience with dual antiplatelet thromboprophylaxis using clopidogrel and aspirin in patients with mechanical prostheses J Heart Valve Dis 18 2009 617 626